Trials / Conditions / To Determine Bioequivalence Under Fasting Conditions

To Determine Bioequivalence Under Fasting Conditions

11 registered clinical trials studyying To Determine Bioequivalence Under Fasting Conditions.

Status	Trial	Sponsor	Phase
Completed	Bioavailability Study of Dronabinol Capsules 10 mg Under Fasting Conditions NCT01380457	Par Pharmaceutical, Inc.	Phase 1
Completed	Bioavailability Study of Propranolol Under Fasting Conditions NCT00653120	Par Pharmaceutical, Inc.	Phase 2
Completed	Bioequivalence Study Doxycycline Tablets and Monodox Capsules Under Fasting Conditions NCT00652795	Par Pharmaceutical, Inc.	Phase 1
Completed	Bioavailability Study of Clonazepam ODT Under Fasting Conditions NCT00652912	Par Pharmaceutical, Inc.	Phase 1
Completed	Bioavailability Study of Clonazepam Tablets Under Fasting Conditions NCT00652639	Par Pharmaceutical, Inc.	Phase 1
Completed	Bioavailability Study of Tramadol/APAP Tablets Under Fasting Conditions NCT00653315	Par Pharmaceutical, Inc.	Phase 1
Completed	Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fasting Conditions NCT00653055	Par Pharmaceutical, Inc.	Phase 1
Completed	Bioavailability Study of Torsemide Tablets Under Fasting Conditions NCT00653549	Par Pharmaceutical, Inc.	Phase 1
Completed	Bioequivalence Study of Doxycycline Monohydrate Tablets Under Fasting Conditions NCT01380483	Par Pharmaceutical, Inc.	Phase 1
Completed	Bioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting Conditions NCT00653380	Par Pharmaceutical, Inc.	Phase 1
Completed	Bioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting Conditions NCT00653419	Par Pharmaceutical, Inc.	Phase 1